We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$324M
AUM Growth
+$15.3M
Cap. Flow
+$2.42M
Cap. Flow %
0.75%
Top 10 Hldgs %
34.73%
Holding
385
New
33
Increased
82
Reduced
62
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 23.71%
2 Miscellaneous 15.43%
3 Healthcare 14.57%
4 Consumer Staples 11.83%
5 Financials 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
26
Automatic Data Processing
ADP
$114B
$3.58M 1.1%
30,515
-525
-2% -$60K
NVDA icon
27
NVIDIA
NVDA
$5.25T
$3.53M 1.09%
730,080
-10,160
-1% -$50.5K
SYK icon
28
Stryker
SYK
$127B
$3.38M 1.04%
21,835
-610
-3% -$93.1K
DD icon
29
DuPont de Nemours
DD
$18.5B
$3.15M 0.97%
17,492
-44
-0.3% -$7.92K
PYPL icon
30
PayPal
PYPL
$45.9B
$3.15M 0.97%
42,754
+974
+2% +$70.4K
BIIB icon
31
Biogen
BIIB
$32.3B
$2.9M 0.89%
9,100
+65
+0.7% +$20.9K
TRP icon
32
TC Energy
TRP
$64.4B
$2.83M 0.87%
58,229
+2,768
+5% +$135K
TD icon
33
Toronto Dominion Bank
TD
$199B
$2.73M 0.84%
46,636
-400
-0.9% -$22.9K
TFX icon
34
Teleflex
TFX
$5.92B
$2.67M 0.82%
10,709
-1,600
-13% -$402K
MSFT icon
35
Microsoft
MSFT
$3.81T
$2.63M 0.81%
30,765
+4,053
+15% +$332K
KO icon
36
Coca-Cola
KO
$386B
$2.49M 0.77%
54,228
+6,751
+14% +$310K
USB.PRM
37
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
$2.34M 0.72%
82,875
-7,350
-8% -$212K
CELG
38
DELISTED
Celgene Corp
CELG
$2.29M 0.71%
21,990
+1,335
+6% +$151K
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.08T
$2.26M 0.7%
11,415
MKC icon
40
McCormick & Company Non-Voting
MKC
$14.9B
$2.05M 0.63%
40,270
+3,100
+8% +$154K
MRK icon
41
Merck
MRK
$366B
$2.02M 0.62%
37,547
-1,969
-5% -$109K
RTX icon
42
RTX Corp
RTX
$285B
$1.91M 0.59%
23,733
+2,097
+10% +$159K
HP icon
43
Helmerich & Payne
HP
$4.25B
$1.81M 0.56%
27,990
+3,010
+12% +$169K
MAR icon
44
Marriott International
MAR
$91.5B
$1.68M 0.52%
12,399
FFIV icon
45
F5
FFIV
$22.3B
$1.66M 0.51%
12,665
-3,605
-22% -$448K
LQD icon
46
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$1.66M 0.51%
13,660
+400
+3% +$48.4K
T icon
47
AT&T
T
$178B
$1.51M 0.47%
51,428
-3,024
-6% -$82.6K
GOOG icon
48
Alphabet (Google) Class C
GOOG
$4.19T
$1.49M 0.46%
28,420
-480
-2% -$24.4K
IMO icon
49
Imperial Oil
IMO
$63.1B
$1.46M 0.45%
46,880
-1,400
-3% -$43.6K
GILD icon
50
Gilead Sciences
GILD
$181B
$1.46M 0.45%
20,315
+745
+4% +$56.6K

Similar funds

American Research & Management Company's Q4 2017 Portfolio in Review

As of Q4 2017, American Research & Management Company held 385 positions worth $324M, up 5% from $309M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

American Research & Management Company's Q4 2017 filing shows 33 new, 82 increased, 62 reduced and 12 closed positions. Its largest new stake was iShares Russell Mid-Cap ETF: 5,724 shares worth $298K. The largest sale was IBM, an estimated $830K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Healthcare.

  • American Research & Management Company's largest Q4 2017 buy was iShares Russell Mid-Cap ETF: 5,724 shares worth $298K.
  • American Research & Management Company added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $938K increase.
  • American Research & Management Company's biggest Q4 2017 reduction was IBM, cutting an estimated $830K.
  • American Research & Management Company fully exited Edwards Lifesciences in Q4 2017, selling an estimated $810K.
  • American Research & Management Company's ten largest holdings make up 35% of its $324M portfolio in Q4 2017.
  • American Research & Management Company opened 33 new positions and closed 12 in Q4 2017.
  • American Research & Management Company's portfolio value rose 5% quarter-over-quarter to $324M.

Based on American Research & Management Company's 13F filing for Q4 2017, filed 8 Feb 2018.